<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>live</title>

    <!-- bootstrap css -->
    <link rel="stylesheet" href="asset/css/bootstrap.min.css" />
    <!-- owl-carousel  -->
    <link rel="stylesheet" href="asset/css/owl.carousel.min.css" />
    <!-- main CSS -->
    <link rel="stylesheet" href="asset/css/main.css" />
</head>

<body>
    <!-- ========================= -->
    <!-- header section  -->
    <!-- ========================= -->
    <div class="header-top-cnt blue">
        <p>THIS SITE IS FOR UK HEALTHCARE PROFESSIONALS ONLY</p>
    </div>
    <header class="header">
        <nav class="navbar navbar-expand-lg navbar-light p-0">
            <div class="collapse navbar-collapse" id="navbarSupportedContent">
                <ul class="navbar-nav align-items-center me-auto">
                    <li class="nav-item">
                        <a href="home.html" class="header-link">
                            <img src="asset/image/Home-icon.png" alt="" />
                            HOME</a>
                    </li>
                    <li class="nav-item active">
                        <a href="patient_experience.html" class="header-link">
                            <img src="asset/image/Patient-icon.png" alt="" />
                            patient experience</a>
                    </li>
                    <li class="nav-item">
                        <a href="about_brintellix.html" class="header-link">
                            <img src="asset/image/AB_ico.png" alt="" />
                            ABOUT BRINTELLIX</a>
                    </li>
                    <li>
                        <a href="#ref" class="header-link ref">
                            <img src="asset/image/AE_icon.png" alt="" />
                            report an adverse Event</a>
                    </li>
                    <li class="nav-item">
                        <a href="asset/pdf/Brintellix Prescribing Information (April 2022) for digital use v5.pdf" target="_blank" class="header-link">
                            <img src="asset/image/PI_icon.png" alt="" />
                            prescribing information</a>
                    </li>
                </ul>
            </div>

            <a class="navbar-brand logo" href="home.html"><img src="asset/image/logo.png" alt="" /></a>
            <button id="nav-burger">
                <span></span>
                <span></span>
                <span></span>
                <span></span>
            </button>
        </nav>
        <hr class="divider" />
    </header>
    <!-- ========================= -->
    <!-- feel section  -->
    <!-- ========================= -->
    <section class="feel-sec ">
        <div class="li li-six" data-parallax="scroll" data-image-src="asset/image/feel-sec-bg6.png" data-z-index="1">
            <div class="nav-btn">
                <a href="maintain.html" class="arrow-btn"><img src="asset/image/left-arrow.png" alt=""></a>
                <a href="feel.html" class="arrow-btn arrow-btn-right"><img src="asset/image/right-arrow.png" alt=""></a>
            </div>
            <div class="container">
                <div class="banner-wraper">
                    <p class="major">
                        Brintellix (vortioxetine) is indicated for the treatment of major
                        depressive episodes in adults.¹<br />
                        Prescribing information can be accessed via the tab at the top of
                        this page.
                    </p>
                    <div class="feel-sec-cnt feel-sec-cnt2">
                        <h2>I want to LIVE</h2>
                        <figure class="feel-image">
                            <img src="asset/image/feel-sec-img5.png" alt="" />
                        </figure>
                        <h3>
                            Could Brintellix’s tolerability profile help adult patients like Samantha who are struggling
                            to stay on medication due to side effects?<sup>1-3</sup>
                        </h3>
                    </div>
                </div>
            </div>
            <ul class="dots-body">
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li class="active"></li>
            </ul>
            <span class="used">Fictional patients used for illustrative purposes.</span>
        </div>

    </section>
    <!-- ========================= -->
    <!-- feelings section  -->
    <!-- ========================= -->
    <section class="feelings cmn-banner">
        <figure class="feelings-bg feelings-bg-sm">
            <img class="feelings-bg1" src="asset/image/feelings-bg2.png" alt="" />
            <img class="display-none" src="asset/image/orange-sm-bg.png" alt="">
        </figure>
        <div class="container">
            <div class="row flex-md-column-reverse flex-sm-column-reverse flex-column-reverse flex-lg-row">
                <div class="col-lg-6">
                    <div class="feelings-cnt-left">
                        <div class="feelings-top-cnt">
                            <h4 class="pb-0">After Samantha started taking an SSRI at the start of this year, she found
                                that it was affecting her sex drive,² leading her to feel disconnected from her husband
                                Robert. </h4>
                            <p class="pb-2">
                                It’s important for Samantha to find a treatment for her MDD that doesn’t affect her
                                intimacy with her husband.
                            </p>
                        </div>
                        <div class="defined-cnt mt-4">
                            <h4>Sexual dysfunction:</h4>
                            <p>
                                Sexual dysfunction is common with serotonergic antidepressants, including SSRIs and
                                SNRIs, and does not resolve in most patients²
                            </p>
                        </div>
                        <span class="font-size-14-white mdd"><strong>MDD,</strong> major depressive disorder; SNRIs,
                            serotonin–norepinephrine reuptake inhibitors; </span>
                    </div>
                </div>
                <div class="col-lg-6">
                    <div class="feelings-cnt-right ">
                        <figure class="round-img">
                            <img src="asset/image/round-img6.png" alt="" />
                        </figure>
                        <h2 class="pb-2">
                            Brintellix’s low rate of sexual dysfunction (5-15 mg* vs. placebo)¹³ may help patients like
                            Samantha who are experiencing sexual dysfunction with their current treatment²
                        </h2>
                        <span class="depressive text-start">*Brintellix 15 mg is not available for use in the UK. The 20
                            mg dose of
                            Brintellix was associated with an increase in sexual dysfunction compared with placebo (an
                            incidence difference of 14.2%)<sup>1</sup> </span>
                    </div>
                </div>
            </div>
        </div>
    </section>
    <!-- ========================= -->
    <!-- desing section  -->
    <!-- ========================= -->
    <section class="design desing2">
        <div class="container2">
            <div class="row desing-row flex-md-column-reverse flex-sm-column-reverse flex-column-reverse flex-lg-row">
                <div class="design-left">
                    <h4 class="see-h4">
                        Brintellix demonstrates a low-rate of patient-reported sexual dysfunction at 5-15 mg* vs.
                        placebo1,¹³
                    </h4>
                    <ul class="both both-3">
                        <li>
                            <span class="week"><strong>Patient-reported sexual dysfunction with Brintellix was low, and similar
                                to that in the placebo group during short-term treatment (1.6-1.8% vs 1.0%)*3</strong></span>
                        </li>
                        <li class="pt-2">
                            <span class="week">*Brintellix 15 mg is not available for use in the UK. The 20 mg dose of
                                Brintellix was associated with an increase in sexual dysfunction compared to placebo (an
                                incidence difference of 14.2%) <sup>1</sup></span>
                        </li>
                    </ul>
                </div>
                <div class="design-right px-4">
                    <div class="desing-right-cnt desing-inner-padding">
                        <h4>For further information about Brintellix, including Tolerability, Special Warnings and
                            Precautions and Contraindications, please visit the About Brintellix Section</h4>
                        <button class="about-brintellix">about brintellix</button>
                    </div>
                </div>
            </div>

        </div>
    </section>
    <!-- ========================= -->
    <!-- desing-2 section  -->
    <!-- ========================= -->
    <section class="design position-relative  " data-parallax="scroll" data-image-src="asset/image/feel-sec-bg5.png"
        data-z-index="1">

        <!-- <figure class="feel-sec-bg">
            <img src="asset/image/desing-bg-img1.png" alt="">
        </figure> -->
        <div class="container2">
            <div
                class="row desing-row flex-md-column-reverse flex-sm-column-reverse flex-column-reverse flex-lg-row-reverse">
                <div class="design-left">
                    <h4 class="see-h4 orange-text">
                        Brintellix demonstrates greater improvement in SSRI-induced treatment-emergent sexual
                        dysfunction compared with escitalopram²
                    </h4>
                    <ul class="both both-2">
                        <li>
                            <span class="week text-white">Switching from an SSRI** to Brintellix was associated with
                                significant clinical improvements in sexual functioning in
                                patients diagnosed with MDD experiencing SSRI-related
                                sexual dysfunction² </span>
                        </li>
                        <li>
                            <span class="week text-white">Improvements in sexual functioning with Brintellix were
                                significantly greater than those with escitalopram at week 8 (p< 0.05) as measured by
                                    change from baseline in the CSFQ-14 total score² </span>
                        </li>
                    </ul>
                    <span class="font-size-14-white">**citalopram, paroxetine, or sertraline <br>
                        CSFQ-14, Changes in Sexual Functioning Questionnaire 14 items; SSRIs, selective serotonin
                        reuptake inhibitors. <br> </span>
                    <button type="button" class="popup-btn study-btn" data-bs-toggle="modal"
                        data-bs-target="#study-modal11">
                        Study design
                    </button>
                </div>
                <div class="design-right">

                </div>
            </div>

        </div>
        <span class="used">Fictional patients used for illustrative purposes.</span>
    </section>

    <!-- ========================= -->
    <!-- warnings section  -->
    <!-- ========================= -->
    <section class="warnings">
        <div class="container">
            <div class="warnings-warp">
                <p>
                    For further information about Brintellix, including Tolerability,
                    Special Warnings and Precautions and Contraindications, please visit
                    the About Brintellix Section
                </p>
                <a href="about_brintellix.html" class="btn-more about-btn">about brintellix</a>
            </div>
        </div>
    </section>
    <!-- ========================= -->
    <!-- deserve section  -->
    <!-- ========================= -->
    <section class="deserve">
        <div class="container">
            <div class="deserve-wrap">
                <h3>Explore more in the sections below:</h3>
            </div>
        </div>
    </section>
    <!-- ========================= -->
    <!-- feel section  -->
    <!-- ========================= -->
    <section class="feel">
        <ul class="feel-body">
            <li class="light-orange">
                <h4>
                    I want to <br />
                    FEEL
                </h4>
                <figure class="feel-img">
                    <img src="asset/image/feel-img1.png" alt="" />
                </figure>
                <div class="function">
                    <p>Brintellix in anhedonia and emotional blunting</p>
                </div>
                <a href="feel.html" class="btn-more btn-more-2">MORE</a>
            </li>
            <li class="light-orange-2">
                <h4>
                    I want to
                    <br />
                    ACHIEVE
                </h4>
                <figure class="feel-img">
                    <img class="feel-img2" src="asset/image/feel-img2.png" alt="" />
                </figure>
                <div class="function">
                    <p>Brintellix in work productivity, presenteeism and functioning</p>
                </div>
                <a href="achieve.html" class="btn-more btn-more-2">MORE</a>
            </li>
            <li class="light-orange-3">
                <h4>
                    I want to <br />
                    MOVE FORWARD
                </h4>
                <figure class="feel-img">
                    <img class="feel-img3" src="asset/image/feel-img3.png" alt="" />
                </figure>
                <div class="function">
                    <p>
                        Brintellix in patients with MDD together with anxiety and a
                        history of trauma
                    </p>
                </div>
                <a href="forward.html" class="btn-more btn-more-2">MORE</a>
            </li>
            <li class="light-orange-4">
                <h4>
                    I want to <br />
                    FOCUS
                </h4>
                <figure class="feel-img">
                    <img src="asset/image/feel-img4.png" alt="" />
                </figure>
                <div class="function">
                    <p>Brintellix in cognition</p>
                </div>
                <a href="focus.html" class="btn-more btn-more-2">MORE</a>
            </li>
            <li class="light-orange-5">
                <h4>
                    I want to <br />
                    MAINTAIN
                </h4>
                <figure class="feel-img">
                    <img src="asset/image/feel-img5.png" alt="" />
                </figure>
                <div class="function">
                    <p>Brintellix in remission and relapse</p>
                </div>
                <a href="maintain.html" class="btn-more btn-more-2">MORE</a>
            </li>
            <li class="light-orange-6">
                <h4>
                    I want to <br />
                    LIVE
                </h4>
                <figure class="feel-img">
                    <img class="feel-img3" src="asset/image/feel-img6.png" alt="" />
                </figure>
                <div class="function">
                    <p>Brintellix and sexual functioning</p>
                </div>

                <a href="live.html" class="btn-more btn-more-2">MORE</a>
            </li>
        </ul>
    </section>
    <!-- ========================= -->
    <!-- reference   section  -->
    <!-- ========================= -->
    <section class="reference" id="ref">
        <div class="container">
            <div class="reference-wrap">
                <div class="adverse-blk">
                    <span class="events">Adverse events should be reported.
                    </span>
                    <p>Reporting forms and information can be found at <a href="#"
                            class="yellowcard">www.mhra.gov.uk/yellowcard</a> Adverse events should
                        also be reported to Lundbeck Limited, Medical Information, on: <a class="mobile-number"
                            href="tel:01908 638972">01908 638972</a> or Email:
                        <a href="mailto:SafetyLuUnitedKingdom@lundbeck.com" class="yellowcard">
                            SafetyLuUnitedKingdom@lundbeck.com</a>

                    </p>

                </div>
                <div class="reference-cnt">
                    <span class="ref-head demi">References</span>
                    <ul class="reference-list">
                        <li>
                            <span>Lundbeck. Brintellix. Summary of Product Characteristics GB and NI.</span>
                        </li>
                        <li>
                            <span>Jacobsen PL et al. J Sex Med 2015;12:2036–2048.
                            </span>
                        </li>
                        <li>
                            <span>Baldwin DS et al. J Psychopharmacol 2016;30:242–252.
                            </span>
                        </li>
                    </ul>
                    <span class="ref-head">UK-BRIN-1285 | June 2023</span>
                </div>
            </div>
        </div>
    </section>
    <!-- ========================= -->
    <!-- footer   section  -->
    <!-- ========================= -->
    <footer>
        <hr class="footer-divider" />
        <div class="container">
            <div class="row">
                <div class="footer-log d-flex">
                    <a href="#" class="footer-logo"><img src="asset/image/footer-logo.png" alt="" /></a>
                </div>
                <div class="location">
                    <p>
                        <strong class="demi">Lundbeck Limited</strong> <br />
                        Iveco House, Station Road <br />
                        Watford, Hertfordshire <br />
                        WD17 1ET <br />
                        United Kingdom
                    </p>
                    <span class="ref-head">UK-BRIN-1360 | June 2023</span>
                </div>
                <div class="contact">
                    <span class="ref-head demi">Contact us </span>
                    <a class="mail-link" href="tel:+44 1908 649 966">+44 1908 649 966</a>
                    <a href="mailto:united_kingdom@lundbeck.com" class="mail-link">united_kingdom@lundbeck.com</a>
                </div>
                <div class="footer-link-cnt">
                    <span class="ref-head demi">Links</span>
                    <ul class="footer-links">
                        <li><a href="contact.html" class="footer-link">Contact us </a></li>
                        <li><a href="terms_of_use.html" class="footer-link">Terms of Use</a></li>
                        <li>
                            <a href="#" class="footer-link">Report an Adverse Event</a>
                        </li>
                        <li>
                            <a href="privacy.html" class="footer-link">Website Privacy Policy</a>
                        </li>
                        <li><a href="cookie_policy.html" class="footer-link">Cookies settings</a></li>
                        <li>
                            <a href="asset/pdf/Brintellix Prescribing Information (April 2022) for digital use v5.pdf" target="_blank" class="footer-link">Prescribing information </a>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </footer>

    <!----------------------- JQUERY ----------------->
    <script src="asset/js/jquery-min.js"></script>

    <!-- BOOTSTRAP JS -->
    <script src="asset/js/bootstrap.bundle.min.js"></script>
    <!----------------------- OWL CAROUSEL ----------------->
    <script src="asset/js/owl.carousel.min.js"></script>
    <!-- script js -->
    <script src="asset/js/script.js"></script>
    <!-- parallax  -->
    <script src="asset/js/parallax.js"></script>
    <!--study 1  Modal -->
    <div class="modal fade" id="study-modal11" tabindex="-1" aria-labelledby="exampleModalLabel" aria-hidden="true">
        <div class="modal-dialog modal-dialog-centered  modal-dialog2">
            <div class="modal-content">
                <div class="modal-header">
                    <button type="button" class="close-btn" data-bs-dismiss="modal" aria-label="Close">
                        <img src="asset/image/close.png" alt="" />
                    </button>
                </div>
                <div class="study-popup-blk">
                    <span class="cao">Jacobsen PL et al. 2015¹</span>
                    <h3>
                        A randomised, double-blind study of Brintellix vs. escitalopram on sexual functioning in
                        patients with major depressive disorder (MDD) experiencing treatment-emergent sexual
                        dysfunction.
                    </h3>
                    <span class="font-size-16-br"><strong>Study objective:</strong> Compare the effects of Brintellix
                        vs. escitalopram on
                        sexual functioning in adults with well-treated major depressive disorder experiencing
                        SSRI-induced sexual dysfunction.</span>
                    <div class="rotate-sm">
                        <figure><img src="asset/image/rotate.png" alt=""></figure>
                        <span class="font-size-16"> Rotate your device for a larger view of the study design</span>
                    </div>
                    <span class="font-size-16-blue pt-3">Eight-week double-blind treatment period</span>
                    <figure class="vocational">
                        <img src="asset/image/vocational-img10.png" alt="" />
                    </figure>
                    <div class="row justify-content-between pt-2 pb-0">
                        <div class="col-lg-5">
                            <span class="  outcome"><strong>Primary outcome:</strong> Change from baseline in the
                                CSFQ-14 total score
                                after eight weeks of treatment.
                            </span>
                        </div>
                        <div class="col-lg-7">
                            <span class="  outcome"><strong>Secondary outcomes: </strong> The MADRS, CGI, and POMS-brief
                                were used to
                                assess antidepressant efficacy. Safety was assessed via adverse events, vital signs,
                                electrocardiograms, laboratory values, weight, and physical examination findings.
                            </span>

                        </div>
                    </div>
                    <div class="licensed  ">
                        <span>CGI-S, Clinical Global Impression - Severity; CSFQ-14, Change in Sexual Functioning
                            Questionnaire 14 items; MADRS, Montgomery-Åsberg Depression Rating Scale; MDE, major
                            depressive episode; POMS-brief, Profile of Mood States brief form; SSRI, selective serotonin
                            reuptake inhibitor.
                        </span>
                        <span><strong>Reference:</strong> 1. Jacobsen PL et al. J Sex Med 2015;12:2036–2048.
                        </span>
                    </div>
                    <div class="inhibitor justify-content-lg-end w-100">
                        <span>UK-BRIN-1285 | June 2023</span>
                    </div>
                </div>
            </div>
        </div>
    </div>
</body>

</html>